Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences London, UK – November 6, 2024 – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system,...